The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Cognition Therapeutics Inc shares valued at $30,001 were purchased by Ricciardi Lisa on Jan 31 ’25. At $0.77 per share, Ricciardi Lisa acquired 38,851 shares. The insider’s holdings grew to 38,851 shares worth approximately $16705.93 following the completion of this transaction.
As published in a research note from B. Riley Securities on December 19, 2024, Cognition Therapeutics Inc [CGTX] has been rated up from a Neutral to a Buy and the price target has been revised to $1.50 from $1. Analysts at Cantor Fitzgerald downgraded the stock from ‘”an Overweight”‘ to ‘”a Neutral”‘ outlook in a report released in late July. As of November 03, 2021, Oppenheimer has initiated its “an Outperform” rating for CGTX. Earlier on November 03, 2021, B. Riley Securities initiated its rating. Their recommendation was “a Buy” for CGTX stock.
Analyzing CGTX Stock Performance
During the last five days, there has been a surge of approximately 2.82%. Over the course of the year, Cognition Therapeutics Inc shares have dropped approximately -39.16%. Shares of the company reached a 52-week high of $0.8993 on 01/06/25 and a 52-week low of $0.3600 on 03/04/25. A 50-day SMA is recorded $0.5960, while a 200-day SMA reached $0.8345.
Support And Resistance Levels for Cognition Therapeutics Inc (CGTX)
According to the 24-hour chart, there is a support level at 0.4024, which, if violated, would cause prices to drop to 0.3781. In the upper region, resistance lies at 0.4605. The next price resistance is at 0.4943. RSI (Relative Strength Index) is 35.33 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.0096, which suggests the price will decrease in the coming days. Percent R is at 41.34%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.
